Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Biotronik Starts First ICD Study Designed To Measure Sex-Specific Outcomes

Executive Summary

BIO-LIBRA will study Biotronik ICDs and CRT-D devices in about 1,000 patients with non-ischemic cardiomyopathy. The investigators expect at least 40% of the subjects in BIO-LIBRA to be women.


Related Content

Women Benefit More From CRT-D, Likely Undertreated, CDRH Finds
Congress Leans On FDA, NIH To Put More Women In Clinical Trials
Clinical Trial Guidance Seeks To Improve Sex-Based Data


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts